Package 59651-545-30

{"route": ["ORAL"], "spl_id": "58ce42c6-10bd-4bb4-bf89-eae8ed82c339", "openfda": {"unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406"], "spl_set_id": ["58ce42c6-10bd-4bb4-bf89-eae8ed82c339"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (59651-545-15)  / 15 TABLET in 1 BLISTER PACK", "package_ndc": "59651-545-15", "marketing_start_date": "20250422"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (59651-545-30)", "package_ndc": "59651-545-30", "marketing_start_date": "20250422"}], "brand_name": "DASATINIB", "product_id": "59651-545_58ce42c6-10bd-4bb4-bf89-eae8ed82c339", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "59651-545", "generic_name": "DASATINIB", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DASATINIB", "active_ingredients": [{"name": "DASATINIB", "strength": "80 mg/1"}], "application_number": "ANDA216547", "marketing_category": "ANDA", "marketing_start_date": "20250422", "listing_expiration_date": "20261231"}